ATXS: Astria Therapeutics Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Astria Therapeutics Inc (ATXS).
$504.52M Market Cap.
ATXS Market Cap. (MRY)
ATXS Shares Outstanding (MRY)
ATXS Assets (MRY)
Total Assets
$342.36M
Total Liabilities
$23.10M
Total Investments
$268.31M
ATXS Income (MRY)
Revenue
$0
Net Income
-$94.26M
Operating Expense
$111.56M
ATXS Cash Flow (MRY)
CF Operations
-$81.21M
CF Investing
-$191.86M
CF Financing
$157.20M
ATXS Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $342,363,000 (34.44%) | $254,666,000 (10.42%) | $230,633,000 (80.87%) | $127,514,000 (168.70%) |
Assets Current | $334,643,000 (33.35%) | $250,942,000 (10.21%) | $227,690,000 (79.18%) | $127,075,000 (174.31%) |
Assets Non-Current | $7,720,000 (107.30%) | $3,724,000 (26.54%) | $2,943,000 (570.39%) | $439,000 (-61.18%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $319,263,000 (31.32%) | $243,116,000 (9.90%) | $221,216,000 (80.86%) | $122,311,000 (200.75%) |
Property Plant & Equipment Net | $5,114,000 (1308.82%) | $363,000 (-61.71%) | $948,000 (140.61%) | $394,000 (-59.21%) |
Cash & Equivalents | $59,820,000 (-65.92%) | $175,530,000 (755.20%) | $20,525,000 (-76.27%) | $86,508,000 (247.00%) |
Accumulated Other Comprehensive Income | $163,000 (0%) | $0 (0%) | -$79,000 (0%) | $0 (0%) |
Deferred Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $268,312,000 (277.90%) | $71,000,000 (-65.52%) | $205,912,000 (427.98%) | $39,000,000 (95.00%) |
Investments Current | $268,312,000 (277.90%) | $71,000,000 (-65.52%) | $205,912,000 (427.98%) | $39,000,000 (95.00%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $4,320,000 (185.53%) | $1,513,000 (92.01%) | $788,000 (-49.39%) | $1,557,000 (0.84%) |
Accumulated Retained Earnings (Deficit) | -$674,794,000 (-16.24%) | -$580,534,000 (-14.36%) | -$507,643,000 (-11.37%) | -$455,809,000 (-74.71%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $5,353,000 (1527.05%) | $329,000 (-64.96%) | $939,000 (157.26%) | $365,000 (-65.11%) |
Debt Current | $1,384,000 (320.67%) | $329,000 (-43.47%) | $582,000 (59.45%) | $365,000 (-43.76%) |
Debt Non-Current | $3,969,000 (0%) | $0 (0%) | $357,000 (0%) | $0 (0%) |
Total Liabilities | $23,100,000 (100.00%) | $11,550,000 (22.65%) | $9,417,000 (80.99%) | $5,203,000 (-23.34%) |
Liabilities Current | $19,131,000 (65.64%) | $11,550,000 (27.48%) | $9,060,000 (74.13%) | $5,203,000 (-18.58%) |
Liabilities Non-Current | $3,969,000 (0%) | $0 (0%) | $357,000 (0%) | $0 (0%) |
ATXS Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $34,452,000 (34.03%) | $25,704,000 (33.60%) | $19,239,000 (29.93%) | $14,807,000 (25.01%) |
Research & Development Expense | $77,106,000 (83.03%) | $42,127,000 (22.95%) | $34,264,000 (120.32%) | $15,552,000 (-39.23%) |
Operating Expenses | $111,558,000 (34.36%) | $83,030,000 (55.19%) | $53,503,000 (-72.56%) | $194,976,000 (420.84%) |
Interest Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$94,260,000 (-29.32%) | -$72,891,000 (-40.62%) | -$51,834,000 (73.41%) | -$194,912,000 (-422.55%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$94,260,000 (-29.32%) | -$72,891,000 (-40.62%) | -$51,834,000 (73.41%) | -$194,912,000 (-422.55%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $24,437,000 (0%) |
Net Income Common Stock | -$94,260,000 (-29.32%) | -$72,891,000 (-40.62%) | -$51,834,000 (76.37%) | -$219,349,000 (-488.07%) |
Weighted Average Shares | $56,161,249 (86.44%) | $30,123,316 (106.03%) | $14,620,618 (63.81%) | $8,925,173 (191.81%) |
Weighted Average Shares Diluted | $56,161,249 (86.44%) | $30,123,316 (106.03%) | $14,620,618 (63.81%) | $8,925,173 (191.81%) |
Earning Before Interest & Taxes (EBIT) | -$94,260,000 (-29.32%) | -$72,891,000 (-40.62%) | -$51,834,000 (73.41%) | -$194,912,000 (-422.55%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$111,558,000 (-34.36%) | -$83,030,000 (-55.19%) | -$53,503,000 (72.56%) | -$194,976,000 (-420.84%) |
ATXS Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$191,863,000 (-242.07%) | $135,052,000 (180.81%) | -$167,129,000 (-1231.17%) | -$12,555,000 (-299.29%) |
Net Cash Flow from Financing | $157,202,000 (77.83%) | $88,398,000 (-38.92%) | $144,721,000 (38.78%) | $104,284,000 (155.22%) |
Net Cash Flow from Operations | -$81,212,000 (-18.65%) | -$68,445,000 (-57.23%) | -$43,533,000 (-44.38%) | -$30,151,000 (7.18%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$115,873,000 (-174.75%) | $155,005,000 (335.07%) | -$65,941,000 (-207.09%) | $61,578,000 (319.61%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $6,466,000 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | -$191,538,000 (-241.80%) | $135,077,000 (180.87%) | -$167,038,000 (-779.15%) | -$19,000,000 (-400.02%) |
Capital Expenditure | -$325,000 (-1200.00%) | -$25,000 (72.53%) | -$91,000 (-333.33%) | -$21,000 (36.36%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $157,202,000 (77.83%) | $88,398,000 (-38.92%) | $144,721,000 (38.78%) | $104,284,000 (155.22%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | $13,042,000 (106.56%) | $6,314,000 (38.65%) | $4,554,000 (35.46%) | $3,362,000 (141.87%) |
Depreciation Amortization & Accretion | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
ATXS Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | -27.40% (21.04%) | -34.70% (9.16%) | -38.20% (87.44%) | -304.10% (-296.48%) |
Return on Average Assets (ROAA) | -26.00% (22.16%) | -33.40% (7.99%) | -36.30% (77.16%) | -158.90% (-135.06%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | -37.50% (72.96%) | -138.70% (-170.90%) | -51.20% (97.91%) | -2451.30% (-877.00%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -5.32 (-67.64%) | -3.17 (24.32%) | -4.19 (-1815.07%) | -0.22 (79.18%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | 1.58 (37.75%) | 1.15 (1.24%) | 1.13 (97.73%) | 0.57 (-45.79%) |
Debt to Equity Ratio (D/E) | 0.07 (50.00%) | 0.05 (11.63%) | 0.04 (0.00%) | 0.04 (-74.25%) |
Earnings Per Share (EPS) | -1.68 (30.58%) | -2.42 (31.83%) | -3.55 (85.56%) | -24.58 (-101.48%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -1.45 (36.12%) | -2.27 (23.83%) | -2.98 (11.74%) | -3.38 (68.20%) |
Book Value Per Share (BVPS) | 5.68 (-29.56%) | 8.07 (-46.66%) | 15.13 (10.41%) | 13.7 (3.06%) |
Tangible Assets Book Value Per Share (TABVPS) | 6.1 (-27.89%) | 8.45 (-46.41%) | 15.78 (10.42%) | 14.29 (-7.92%) |
Enterprise Value Over EBIT (EV/EBIT) | -5 (-150.00%) | -2 (50.00%) | -4 (0%) | 0 (0%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -4.55 (-108.23%) | -2.19 (44.87%) | -3.97 (-1363.38%) | 0.31 (35.34%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 17.49 (-19.49%) | 21.73 (-13.55%) | 25.13 (2.90%) | 24.42 (236.87%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$81,537,000 (-19.08%) | -$68,470,000 (-56.95%) | -$43,624,000 (-44.58%) | -$30,172,000 (7.21%) |
Enterprise Value (EV) | $429,260,918 (169.24%) | $159,436,747 (-22.47%) | $205,645,537 (436.49%) | -$61,114,919 (-605.02%) |
Earnings Before Tax (EBT) | -$94,260,000 (-29.32%) | -$72,891,000 (-40.62%) | -$51,834,000 (73.41%) | -$194,912,000 (-422.55%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$94,260,000 (-29.32%) | -$72,891,000 (-40.62%) | -$51,834,000 (73.41%) | -$194,912,000 (-422.55%) |
Invested Capital | $268,765,000 (295.74%) | $67,915,000 (-66.38%) | $201,987,000 (458.47%) | $36,168,000 (110.50%) |
Working Capital | $315,512,000 (31.80%) | $239,392,000 (9.50%) | $218,630,000 (79.39%) | $121,872,000 (205.18%) |
Tangible Asset Value | $342,363,000 (34.44%) | $254,666,000 (10.42%) | $230,633,000 (80.87%) | $127,514,000 (168.70%) |
Market Capitalization | $504,521,918 (80.99%) | $278,754,747 (11.26%) | $250,535,537 (257.29%) | $70,121,081 (63.15%) |
Average Equity | $343,932,250 (63.90%) | $209,839,250 (54.52%) | $135,798,250 (88.29%) | $72,123,500 (48.29%) |
Average Assets | $362,699,500 (66.03%) | $218,455,000 (53.20%) | $142,599,000 (3.27%) | $138,082,000 (150.41%) |
Invested Capital Average | $251,377,000 (378.18%) | $52,569,000 (-48.10%) | $101,280,000 (1173.72%) | $7,951,500 (-46.50%) |
Shares | 56,434,219 (55.48%) | 36,296,191 (115.72%) | 16,825,758 (29.33%) | 13,009,477 (288.64%) |
